Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study

BACKGROUND: Since renal cell carcinoma(RCC) is insensitive to conventional chemoradiotherapy, molecularly targeted drugs are commonly used treatments for unresectable advanced RCC. The aim of this study was to explore the efficacy and safety of TACE + sunitinib vs. sunitinib in the treatment of unre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haohao, Ye, Qing, Zheng, Chuansheng, Fan, Li, Xia, Xiangwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037847/
https://www.ncbi.nlm.nih.gov/pubmed/36964538
http://dx.doi.org/10.1186/s12885-023-10754-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037847/
https://www.ncbi.nlm.nih.gov/pubmed/36964538
http://dx.doi.org/10.1186/s12885-023-10754-0

Ejemplares similares